Certain blood biomarkers may predict women’s heart disease risk early
Image credit: hieptltb97 via Unsplash
A recent study published in The New England Journal of Medicine has identified three key blood biomarkers that may help women assess their risk for heart disease years before symptoms appear. Low-density lipoprotein, high-sensitivity C-reactive protein, and lipoprotein(a), which indicate inflammation and cardiovascular strain, could offer a proactive tool for early detection, allowing women to take preventive measures long before heart disease develops. By monitoring these biomarkers, healthcare providers can tailor treatments and lifestyle recommendations to reduce long-term risk, transforming heart disease prevention for women.
Source
Ridker, P. M., Moorthy, M. V., Cook, N. R., Rifai, N., Lee, I. M., & Buring, J. E. (2024). Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women. The New England journal of medicine, 10.1056/NEJMoa2405182. Advance online publication. https://doi.org/10.1056/NEJMoa2405182
Additional Reading
https://www.cnn.com/2024/08/31/health/blood-biomarkers-women-heart-disease-risks/index.html